Enhancing Immune Checkpoint Inhibitor therapy in Kidney Cancer
Technical Report,30 Sep 2018,30 Sep 2019
UT Southwestern Medical Center Dallas United States
Pagination or Media Count:
The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to testdifferent strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Animal Protocol is now ACURO and UTSW approved. Work will start as soon as no cost extension has been approved.
- Medicine and Medical Research